Johannes C. Melms

5.1k total citations
15 papers, 240 citations indexed

About

Johannes C. Melms is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Johannes C. Melms has authored 15 papers receiving a total of 240 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Johannes C. Melms's work include CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immune cells in cancer (3 papers). Johannes C. Melms is often cited by papers focused on CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immune cells in cancer (3 papers). Johannes C. Melms collaborates with scholars based in United States, Germany and Israel. Johannes C. Melms's co-authors include Benjamin Izar, Sigrid C. Schwarz, Frank Weber, Benno Pütz, Heike Rübsamen, Markus Krumbholz, Edgar Meinl, Hans von Faber, Reinhard Hohlfeld and Peter Weber and has published in prestigious journals such as Cell, Nature Biotechnology and Cancer Research.

In The Last Decade

Johannes C. Melms

13 papers receiving 236 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johannes C. Melms United States 8 102 65 51 39 34 15 240
Giulia Manferrari United Kingdom 4 109 1.1× 60 0.9× 114 2.2× 48 1.2× 17 0.5× 4 289
Faisal Hayat Nazir Sweden 9 112 1.1× 26 0.4× 69 1.4× 30 0.8× 20 0.6× 17 292
Anhui Yao China 9 78 0.8× 29 0.4× 91 1.8× 72 1.8× 28 0.8× 20 308
Claudio Derada Troletti Netherlands 7 147 1.4× 31 0.5× 72 1.4× 88 2.3× 32 0.9× 7 333
Ali Moussavi Nik Sweden 8 153 1.5× 41 0.6× 19 0.4× 52 1.3× 18 0.5× 10 267
Kris Janssens Belgium 9 65 0.6× 52 0.8× 102 2.0× 69 1.8× 14 0.4× 11 261
Shisi Wang China 7 75 0.7× 20 0.3× 46 0.9× 33 0.8× 51 1.5× 23 216
Anna Ronowicz Poland 7 126 1.2× 22 0.3× 51 1.0× 65 1.7× 18 0.5× 9 258
Μαρία Καραμίτα Greece 7 78 0.8× 30 0.5× 78 1.5× 84 2.2× 25 0.7× 10 288
Hieu Minh Ta Japan 9 138 1.4× 127 2.0× 173 3.4× 51 1.3× 19 0.6× 14 407

Countries citing papers authored by Johannes C. Melms

Since Specialization
Citations

This map shows the geographic impact of Johannes C. Melms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes C. Melms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes C. Melms more than expected).

Fields of papers citing papers by Johannes C. Melms

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johannes C. Melms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes C. Melms. The network helps show where Johannes C. Melms may publish in the future.

Co-authorship network of co-authors of Johannes C. Melms

This figure shows the co-authorship network connecting the top 25 collaborators of Johannes C. Melms. A scholar is included among the top collaborators of Johannes C. Melms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johannes C. Melms. Johannes C. Melms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Caprio, Lindsay, Luke L. Cai, Shivem B. Shah, et al.. (2025). micronuclAI enables automated quantification of micronuclei for assessment of chromosomal instability. Communications Biology. 8(1). 361–361. 1 indexed citations
2.
Frangieh, Chris J., Neeharika Kothapalli, Jay A. Levy, et al.. (2025). Scalable generation and functional classification of genetic variants in inborn errors of immunity to accelerate clinical diagnosis and treatment. Cell. 188(18). 4861–4879.e27. 1 indexed citations
3.
Shah, Parin, Neeharika Kothapalli, Shivem B. Shah, et al.. (2024). Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens. Nature Biotechnology. 43(3). 384–395. 18 indexed citations
4.
Caprio, Lindsay, Christy Hong, Amit Dipak Amin, et al.. (2024). Abstract 5360: Relief of chromosomal instability-induced cGAS-STING signaling sensitizes STK11-mutant non-small cell lung cancer to immune checkpoint blockade. Cancer Research. 84(6_Supplement). 5360–5360.
5.
Shah, Parin, Blake Caldwell, Johannes C. Melms, et al.. (2024). Single-Cell Profiling of Sarcomas from Archival Tissue Reveals Programs Associated with Resistance to Immune Checkpoint Blockade. Clinical Cancer Research. 30(19). 4530–4541.
6.
Ager, Casey R., Mingxuan Zhang, Matthew G. Chaimowitz, et al.. (2023). KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response. Journal for ImmunoTherapy of Cancer. 11(9). e006782–e006782. 7 indexed citations
7.
Melms, Johannes C., et al.. (2023). From patient tissue correlates to molecular mechanisms of cancer immune evasion: the emerging role of CD58 and PD-L1 co-regulation via CMTM6. Genes and Immunity. 25(1). 82–84. 3 indexed citations
8.
Cartwright, Adam N.R., Shengbao Suo, S Badrinath, et al.. (2021). Immunosuppressive Myeloid Cells Induce Nitric Oxide–Dependent DNA Damage and p53 Pathway Activation in CD8+ T Cells. Cancer Immunology Research. 9(4). 470–485. 34 indexed citations
9.
Garrido, Amanda, Eunjeong Kim, Ana Teijeiro, et al.. (2021). Histone acetylation of bile acid transporter genes plays a critical role in cirrhosis. Journal of Hepatology. 76(4). 850–861. 34 indexed citations
10.
Sengupta, Soma, Tahseen H. Nasti, Milota Kaluzová, et al.. (2020). 20. MELANOMA CELL INTRINSIC GABAA RECEPTOR ENHANCEMENT POTENTIATES RADIATION AND IMMUNE CHECKPOINT INHIBITOR RESPONSE BY PROMOTING DIRECT AND T CELL-MEDIATED ANTI-TUMOR ACTIVITY. Neuro-Oncology Advances. 2(Supplement_2). ii3–ii3. 2 indexed citations
11.
Thummalapalli, Rohit, Johannes C. Melms, James W. Mier, & Benjamin Izar. (2019). Rapid evolution of acute kidney injury after initial infusion of pembrolizumab in a melanoma patient concurrently treated with RAF/MEK inhibitors. Melanoma Research. 30(2). 219–222. 2 indexed citations
12.
Melms, Johannes C., Rohit Thummalapalli, Huihui Ye, et al.. (2018). Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic. Journal for ImmunoTherapy of Cancer. 6(1). 89–89. 10 indexed citations
13.
Melms, Johannes C., Rohit Thummalapalli, Titus J. Brinker, et al.. (2018). Implementation of cell‑free tumor DNA sequencing from the cerebrospinal fluid to guide treatment in a patient with primary leptomeningeal melanoma: A case report. Molecular and Clinical Oncology. 9(1). 58–61. 10 indexed citations
14.
Höllerhage, Matthias, Claudia Moebius, Johannes C. Melms, et al.. (2017). Protective efficacy of phosphodiesterase-1 inhibition against alpha-synuclein toxicity revealed by compound screening in LUHMES cells. Scientific Reports. 7(1). 11469–11469. 49 indexed citations
15.
Hoffmann, Franziska, Heike Rübsamen, Johannes C. Melms, et al.. (2015). Fingolimod induces neuroprotective factors in human astrocytes. Journal of Neuroinflammation. 12(1). 184–184. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giulia Manferrari Breakdown of academic impact, for papers by Faisal Hayat Nazir Breakdown of academic impact, for papers by Anhui Yao Breakdown of academic impact, for papers by Claudio Derada Troletti Breakdown of academic impact, for papers by Ali Moussavi Nik Breakdown of academic impact, for papers by Kris Janssens Breakdown of academic impact, for papers by Shisi Wang Breakdown of academic impact, for papers by Anna Ronowicz Breakdown of academic impact, for papers by Μαρία Καραμίτα Breakdown of academic impact, for papers by Hieu Minh Ta
Rankless by CCL
2026